Saba Capital Management »

Ys Biopharma shares owned by Saba Capital Management

Quarter-by-quarter ownership of Ys Biopharma (LSBPW) shares owned by Saba Capital Management from 13F filings

Historical chart of Saba Capital Management investment in Ys Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Ys Biopharma held by Saba Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ys Biopharma by Saba Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.5k 97k 0.06
2024-03-31 $7.0k 97k 0.07
2023-12-31 $3.2k 97k 0.03
2023-09-30 $4.0k 97k 0.04
2023-06-30 $5.3k 97k 0.05
2023-03-31 $15k 97k 0.16

More positions owned by Saba Capital Management

Ishares Tr Russell 2000 Etf Call Option (IWM)
Blackrock Esg Cap Allc Term Shs Ben Int (ECAT)
Blackrock Innovation And Grw Shs Ben Int (BIGZ)
Blackrock Health Sciences Te Com Shs (BMEZ)
Blackrock Capital Allocation Trust (BCAT)
Adams Express Company (ADX)
Pimco Dynamic Income Strateg Com Shs Ben Int (PDX)
Blackrock Science & Technolo Shs Ben Int (BSTZ)
Nuveen CA Dividend Advantage Muni. Fund (NAC)
Gabelli Dividend & Income Trust (GDV)
Mainstay Cbre Global (MEGI)
Nuveen Nj Div Advantage Mun (NXJ)
Neuberger Berman Next Genera Common Stock (NBXG)
American Airls Put Option (AAL)
Invesco Van Kampen Muni Opp Trust (VMO)

View all positions for Saba Capital Management

Top funds holding Ys Biopharma

LMR Partners
Valliance Asset Management
Jane Street
Highbridge Capital Management
Bracebridge Capital
Cowen And Company
Calamos Advisors
Q Global Advisors
Whitebox Advisors
D. E. Shaw & Co
Saba Capital Management
Cantor Fitzgerald, L. P.
Shaolin Capital Management
Deutsche Bank Aktiengesellschaft
Clear Street

View all funds holding Ys Biopharma